Fistula News and Research

RSS

A Fistula is an abnormal opening or passage between two organs or between an organ and the surface of the body. Fistulas may be caused by injury, infection, or inflammation, or may be created during surgery.

HeRO graft device provides long-term AV access for hemodialysis patients

University Hospitals Case Medical Center physicians are utilizing a novel approach to solve a long standing problem for chronic kidney disease patients on hemodialysis.

5 Nov 2011

Rwandan government, UNFPA step up campaign to end obstetric fistula

The United Nations Population Fund (UNFPA), the World Food Program and Engender Health have partnered with Rwanda's Ministry of Health in "a campaign to treat and end obstetric fistula in women in Rwanda," the New Times/AllAfrica.com reports.

11 Oct 2011

NGOs, government face challenges in preventing fistula in DRC

Inter Press Service examines the challenges that non-governmental organizations and the government face in trying to prevent fistula among women in the Democratic Republic of Congo, where an estimated 12,000 cases are recorded annually because of sexual violence, early marriage and complications in childbirth, according to the Ministry of Public Health. Poverty, early pregnancy and marriage, sexual violence, and a lack of education and knowledge about the condition contribute to its prevalence, IPS reports.

30 Sep 2011

Photo essay of USAID's work with women suffering from fistula in Guinea

This post in USAID's "IMPACTblog" examines the agency's work with women suffering from obstetric fistula in Guinea, where "[t]he average ... woman will have six children during her lifetime" and "due to the lack of obstetric care," many develop the "painful injury that is especially traumatic due to the stigma associated with it."

29 Sep 2011

TrustLaw publishes special report on child marriage

TrustLaw, a Thomson Reuters Foundation service, on Thursday published a series of articles, infographics and videos in a special report on child marriage. According to the series homepage, "every day, 25,000 girls under the age of 18 are married worldwide. For many child brides, a future of poverty, exploitation and poor health awaits".

5 Aug 2011

Study shows fall in blood pressure during dialysis for patients increases risk of blood clotting

A sudden drop in blood pressure while undergoing dialysis has long vexed many kidney patients. Side effects associated with this situation over the long term range from stroke to seizure to heart damage to death.

30 Jul 2011

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

Janssen Biotech, Inc., formerly Centocor Ortho Biotech Inc., announced today that the Gastrointestinal Drugs Advisory Committee of the U.S. Food and Drug Administration recommended the approval of REMICADE for the treatment of moderately to severely active ulcerative colitis in pediatric patients who have had an inadequate response to conventional therapy.

22 Jul 2011

Artegraft BCA superior to cuffed ePTFE for hemodialysis access

Artegraft, Inc. announces that a three-year prospective, randomized clinical study published in the June 2011 issue of the Journal of Vascular Surgery confirms the superiority of Artegraft Bovine Carotid Artery vascular grafts (BCA) to cuffed ePTFE grafts.

21 Jul 2011

Gene-based test for distinguishing harmless from precancerous pancreatic cysts

Johns Hopkins scientists have developed a gene-based test to distinguish harmless from precancerous pancreatic cysts. The test may eventually help some patients avoid needless surgery to remove the harmless variety.

21 Jul 2011

DaVita's catheter-reduction program lowers CVC rates in hemodialysis patients

DaVita Inc., a leading provider of kidney care services for those diagnosed with end stage renal disease (ESRD) and chronic kidney disease (CKD), today announced that the company has made landmark progress in reducing "Day 90+" patient central venous catheter (CVC) rates, further cementing its position as the industry leader among large dialysis organizations in catheter reductions through the placement of permanent accesses.

14 Jul 2011

FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer

Genentech, a member of the Roche Group, announced today that, during a U.S. Food and Drug Administration (FDA) hearing, the FDA's Oncologic Drugs Advisory Committee (ODAC) recommended that the FDA withdraw its approval of Avastin in combination with paclitaxel chemotherapy for previously untreated HER2-negative metastatic breast cancer.

30 Jun 2011

MRE reduces ionizing radiation exposure, detects Crohn's disease as reliably as CT

A new study from Rhode Island Hospital has found that MR enterography (MRE) without the use of an anti-peristaltic agent were as reliable as CT enterography (CTE) in determining the presence of Crohn's disease.

16 Jun 2011

Secretary of State Clinton travels to sub-Saharan Africa

Secretary of State Hillary Rodham Clinton is embarking on a weeklong trip to sub-Saharan Africa, CNN reports.

13 Jun 2011

ACS honors Los Angeles general surgeon with 2011 Jacobson Innovation Award

George Berci, MD, FACS, FRCS, Ed. (Hon), a general surgeon from Los Angeles, CA, is the recipient of the 2011 Jacobson Innovation Award of the American College of Surgeons.

13 Jun 2011

Celgene announces results of REVLIMID, docetaxel/prednisone phase II combination study on mCRPC

Celgene International Sàrl today announced results from a phase II investigator initiated study of REVLIMID (lenalidomide) in combination with Avastin (bevacizumab), docetaxel and prednisone in patients with metastatic castration-resistant prostate cancer were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, Ill.

6 Jun 2011

Genentech's Avastin, chemotherapy Phase III combination study data on ovarian cancer presented at ASCO

Genentech, a member of the Roche Group, today announced results from OCEANS, a Phase III study evaluating Avastin (bevacizumab) in combination with chemotherapy followed by the continued use of Avastin alone in women with previously treated (recurrent) platinum-sensitive ovarian cancer.

6 Jun 2011

Promising results from Exelixis' cabozantinib phase 2 trial against metastatic ovarian cancer

Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.

6 Jun 2011

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

Genentech, a member of the Roche Group, today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin in ovarian cancer, will be presented at the 47th Annual Meeting of the American Society of Clinical Oncology.

18 May 2011

Studies emphasize need to avoid central venous catheters in patients on hemodialysis

Patients on peritoneal dialysis (PD) typically have a higher early survival rate than patients on hemodialysis (HD). New data suggest that this difference may be explained by a higher risk of early deaths among patients undergoing HD with central venous catheters, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).

22 Apr 2011

Decision Resources: 68% of gastroenterologists select Remicade for Crohn's treatment

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that more than two-thirds of surveyed gastroenterologists selected Centocor Ortho Biotech/Merck & Co./Mitsubishi Tanabe's Remicade as the most efficacious therapy for Crohn's disease, when compared to other currently available agents.

24 Mar 2011

Fistula News and Research

Further Reading

HeRO graft device provides long-term AV access for hemodialysis patients

Rwandan government, UNFPA step up campaign to end obstetric fistula

NGOs, government face challenges in preventing fistula in DRC

Photo essay of USAID's work with women suffering from fistula in Guinea

TrustLaw publishes special report on child marriage

Study shows fall in blood pressure during dialysis for patients increases risk of blood clotting

GIDAC recommends FDA approval of Janssen's REMICADE for treatment of pediatric UC

Artegraft BCA superior to cuffed ePTFE for hemodialysis access

Gene-based test for distinguishing harmless from precancerous pancreatic cysts

DaVita's catheter-reduction program lowers CVC rates in hemodialysis patients

FDA's ODAC recommends withdrawal of Avastin approval for metastatic breast cancer

MRE reduces ionizing radiation exposure, detects Crohn's disease as reliably as CT

Secretary of State Clinton travels to sub-Saharan Africa

ACS honors Los Angeles general surgeon with 2011 Jacobson Innovation Award

Celgene announces results of REVLIMID, docetaxel/prednisone phase II combination study on mCRPC

Genentech's Avastin, chemotherapy Phase III combination study data on ovarian cancer presented at ASCO

Promising results from Exelixis' cabozantinib phase 2 trial against metastatic ovarian cancer

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

Studies emphasize need to avoid central venous catheters in patients on hemodialysis

Decision Resources: 68% of gastroenterologists select Remicade for Crohn's treatment

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News